rs114396665

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014956.5(CEP164):​c.1480C>A​(p.Pro494Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,603,380 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P494R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0065 ( 15 hom., cov: 33)
Exomes 𝑓: 0.00068 ( 7 hom. )

Consequence

CEP164
NM_014956.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0460

Publications

3 publications found
Variant links:
Genes affected
CEP164 (HGNC:29182): (centrosomal protein 164) This gene encodes a centrosomal protein involved in microtubule organization, DNA damage response, and chromosome segregation. The encoded protein is required for assembly of primary cilia and localizes to mature centrioles. Defects in this gene are a cause of nephronophthisis-related ciliopathies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CEP164 Gene-Disease associations (from GenCC):
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • nephronophthisis 15
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, G2P
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003118813).
BP6
Variant 11-117381771-C-A is Benign according to our data. Variant chr11-117381771-C-A is described in ClinVar as Benign. ClinVar VariationId is 540297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0065 (990/152240) while in subpopulation AFR AF = 0.0227 (944/41524). AF 95% confidence interval is 0.0215. There are 15 homozygotes in GnomAd4. There are 482 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP164NM_014956.5 linkc.1480C>A p.Pro494Thr missense_variant Exon 13 of 33 ENST00000278935.8 NP_055771.4 Q9UPV0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP164ENST00000278935.8 linkc.1480C>A p.Pro494Thr missense_variant Exon 13 of 33 1 NM_014956.5 ENSP00000278935.3 Q9UPV0-1
CEP164ENST00000533675.5 linkn.1735C>A non_coding_transcript_exon_variant Exon 9 of 27 2
CEP164ENST00000533706.5 linkn.804C>A non_coding_transcript_exon_variant Exon 6 of 27 5

Frequencies

GnomAD3 genomes
AF:
0.00649
AC:
988
AN:
152122
Hom.:
15
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0228
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00153
AC:
341
AN:
222628
AF XY:
0.00119
show subpopulations
Gnomad AFR exome
AF:
0.0231
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000726
GnomAD4 exome
AF:
0.000676
AC:
981
AN:
1451140
Hom.:
7
Cov.:
30
AF XY:
0.000583
AC XY:
420
AN XY:
720824
show subpopulations
African (AFR)
AF:
0.0244
AC:
812
AN:
33248
American (AMR)
AF:
0.00126
AC:
55
AN:
43598
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25816
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39320
South Asian (SAS)
AF:
0.0000950
AC:
8
AN:
84230
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52474
Middle Eastern (MID)
AF:
0.000705
AC:
4
AN:
5670
European-Non Finnish (NFE)
AF:
0.0000208
AC:
23
AN:
1106868
Other (OTH)
AF:
0.00132
AC:
79
AN:
59916
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00650
AC:
990
AN:
152240
Hom.:
15
Cov.:
33
AF XY:
0.00648
AC XY:
482
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0227
AC:
944
AN:
41524
American (AMR)
AF:
0.00164
AC:
25
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68022
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
47
94
141
188
235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00202
Hom.:
4
Bravo
AF:
0.00740
ExAC
AF:
0.00184
AC:
222

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

CEP164-related disorder Benign:1
Aug 05, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Nephronophthisis 15 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
6.4
DANN
Uncertain
0.99
DEOGEN2
Benign
0.041
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.44
FATHMM_MKL
Benign
0.096
N
LIST_S2
Benign
0.78
T
MetaRNN
Benign
0.0031
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.9
L
PhyloP100
-0.046
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.090
Sift
Uncertain
0.016
D
Sift4G
Benign
0.14
T
Polyphen
0.98
D
Vest4
0.25
MVP
0.48
MPC
0.40
ClinPred
0.018
T
GERP RS
2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.063
gMVP
0.22
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114396665; hg19: chr11-117252487; API